Go to the list of all blogs
Alicia's Avatar
published in Blogs
May 18, 2026
Why Is Aeluma, Inc. (ALMU) Stock Down -16% Today?

Why Is Aeluma, Inc. (ALMU) Stock Down -16% Today?

Key Takeaways

  • Shares of ALMU are declining approximately 16.00% on Monday, May 18, 2026, falling from a Friday, May 15 close of $24.86 to approximately $20.88 — a third consecutive session of post-earnings selling that has now erased approximately 33.7% of ALMU's value from the May 13 pre-earnings close of $31.49, as the market continues to reprice the stock following the May 13 Q3 FY2026 report that delivered a revenue miss and a significant full-year guidance cut attributing contract delays directly to U.S. government shutdown disruptions.

  • The primary catalyst for this three-session decline is the full-year FY2026 revenue guidance reduction from $4.0M–$6.0M to $4.2M–$4.6M — a cut that eliminates $1.4 million from the top end of the outlook and compresses the potential revenue range to just $400,000 — while citing delays in government contracts as the specific driver, a disclosure that directly implicates federal spending uncertainty under the current administration's budget environment as a structural revenue risk for a company whose revenue base is almost entirely dependent on defense, aerospace, NASA, and DARPA contract flows.

  • Q3 FY2026 revenue of $1.22 million missed the $1.38 million analyst estimate by 11.6%, confirming that the government contract delay headwind was not a forward-looking warning but an already-realized drag on the quarter just reported, and that Q4 FY2026 revenue will be similarly constrained by the $4.2M–$4.6M guidance ceiling that implies only $770,000–$1.17 million in remaining Q4 revenue.

  • A compounding technical deterioration is accelerating today's selling: ALMU's Momentum Indicator crossed below zero on May 15, the 10-day RSI exited overbought territory on May 14, and the stock broke below its upper Bollinger Band following the May 5 breakout — a convergence of bearish technical signals that is attracting systematic stop-loss and momentum-reversal selling on top of the fundamental post-earnings repricing.

  • The macro backdrop is adding pressure: Moody's U.S. sovereign credit rating downgrade from Aaa to Aa1, announced Friday evening, has created a risk-off Monday session that is particularly penalizing speculative small-cap semiconductor and defense-tech names with government contract revenue dependencies and negative operating cash flow.

  • Traders will watch the $20.00 psychological support level and any mid-quarter update from management regarding the status of the government contract delays — specifically whether the DARPA, Navy, and NASA contract timelines are experiencing temporary deferrals or permanent scope reductions that would threaten even the narrowed $4.2M–$4.6M guidance floor.

Opening Summary

Aeluma, Inc. (ALMU) is a Goleta, California-based semiconductor company specializing in high-performance, scalable compound semiconductor technologies — including indium gallium arsenide (InGaAs) photodetectors, quantum dot lasers, and nonlinear photonic materials — for applications in mobile 3D sensing, AI hardware, defense and aerospace, robotics, automotive, augmented and virtual reality, and quantum computing, with an active contract base that includes a $11.717 million DARPA contract and agreements with NASA and the U.S. Navy to advance scalable quantum and sensing technologies, and approximately $37.8 million in cash as of March 31, 2026. Shares are plunging approximately 16.00% on Monday, May 18, 2026, falling from a Friday, May 15 close of $24.86 to approximately $20.88, as ALMU's post-earnings correction extends into a third consecutive session following the May 13 Q3 FY2026 results that cut full-year guidance and missed revenue estimates — with today's decline compounded by bearish technical momentum signals and the broader macro risk-off environment triggered by Moody's U.S. credit downgrade.

Q3 FY2026 Earnings: Guidance Cut Is the Critical Catalyst

The Q3 FY2026 financial results released after the close on May 13 delivered a non-GAAP EPS of -$0.04 that met the consensus estimate of -$0.04 — but the EPS beat is largely irrelevant relative to the two metrics that actually define ALMU's near-term value. First, Q3 FY2026 revenue of $1.22 million missed the $1.38 million estimate by 11.6%, with the year-over-year comparison also slightly below the prior period. Second — and far more damaging — management narrowed the full-year FY2026 revenue guidance from the previously issued $4.0M–$6.0M range to $4.2M–$4.6M, explicitly attributing the top-end reduction to delays in government contracts caused by U.S. government shutdown disruptions. The guidance cut matters disproportionately for ALMU because the company had generated enormous investor enthusiasm in mid-April 2026 — producing a 49.8% rally — after announcing over $4 million in U.S. government contracts for quantum dot lasers and nonlinear photonic materials. That announcement established government contract wins as the primary fundamental re-rating catalyst. The May 13 guidance cut that cites government contract delays as a near-term revenue headwind directly undercuts the same government contract narrative that drove the prior rally, creating a sell-the-news dynamic that has now accelerated over three consecutive sessions totaling approximately 33.7% in combined losses.

Government Contract Risk: DOGE-Era Federal Spending Uncertainty

The specific mechanism behind ALMU's guidance cut — government shutdown-related contract delays — reflects a structural risk that is directly attributable to the current federal budget environment under the Trump administration's Department of Government Efficiency (DOGE) initiative, which has generated recurring federal spending uncertainty, contract review processes, and agency-level budget realignments that are creating measurable delays in defense and aerospace procurement timelines. ALMU's revenue base is almost entirely dependent on DARPA, NASA, and Navy contract flows — agencies that have experienced disruption from the ongoing federal budget restructuring process. The narrowing of ALMU's guidance to $4.2M–$4.6M is essentially management acknowledging that the federal procurement delays are not temporary administrative processing lags but a materially longer disruption that is expected to persist through at least Q4 FY2026, ending June 30, 2026. For a company whose entire commercial ramp-up thesis is premised on government agencies converting quantum dot laser and photonic materials interest into contracted purchase orders, any extension of the procurement delay beyond Q4 FY2026 would call into question the FY2027 revenue trajectory that justifies ALMU's current valuation even at Monday's $20.88 post-decline level.

Market Context and Trading Activity

Volume in ALMU on Monday, May 18 is running at elevated levels relative to the 30-day average, as the convergence of three independent selling forces — post-earnings fundamental repricing, bearish technical momentum crossovers, and macro risk-off pressure — generates a session where no single counterforce is large enough to absorb the supply. At $20.88, ALMU has fallen below the $21.00–$22.00 zone that represented pre-April-rally support, and is approaching the $20.00 psychological floor below which technical selling could accelerate toward the $17.55 level from which the stock began 2026. The broader defense-technology and photonics semiconductor sector is under mixed-to-negative pressure Monday, with the Moody's sovereign downgrade contributing a macro headwind that is disproportionate to fundamentals for government-contract-dependent small-cap technology names. Notably, ALMU's GAAP net loss of $1.8 million in Q3, against cash of $37.8 million, implies a runway of approximately five to six additional years at the current quarterly burn rate — providing fundamental support that should limit a valuation collapse even as the near-term revenue headwind from government contract delays creates ongoing technical pressure.

Trending AI Robots

For traders navigating post-earnings guidance cut corrections and government contract delay repricing events in defense photonics and compound semiconductor companies like ALMU today, Tickeron's Trending AI Robots page provides a curated view of the platform's strongest-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers, but only those demonstrating the highest real-time performance are featured in this section. Bots span a wide range of strategy types, holding timeframes, risk profiles, performance metrics, and traded symbols — from post-earnings momentum exhaustion and guidance cut mean-reversion frameworks for government-dependent quantum photonics and semiconductor names to systematic strategies built to identify technical support zones following multi-session post-earnings corrections in DARPA and NASA-contracted deep-tech developers. Whether you are managing risk around a sustained post-earnings correction in a leading quantum dot laser and InGaAs photodetector company or identifying structured setups across the broader defense semiconductor and photonic computing landscape, the Trending AI Robots page is a practical starting point for AI-assisted trading.

What Comes Next for ALMU

The Q4 FY2026 earnings release — covering the quarter ending June 30, 2026, and expected in mid-August 2026 — will provide the definitive test of whether the government contract delays cited in ALMU's FY2026 guidance cut are temporary or structural: the narrowed $4.2M–$4.6M guidance implies Q4 FY2026 revenue of only $770,000–$1.17 million — the lowest quarterly revenue output since early FY2025 — and any outcome above this floor would represent the beginning of the government contract normalization that management appears to be expecting in Q1 FY2027 and beyond. Critical near-term watchpoints include any press release from ALMU announcing incremental government contract awards — particularly from DARPA for photonic computing or quantum applications, or from the U.S. Navy for advanced sensing — that would signal the contract delay is indeed temporary and that FY2027 contract flows are materializing. Key risks include the possibility that the DOGE-driven federal procurement environment creates delays that extend into H1 FY2027, preventing ALMU's management from providing meaningful FY2027 revenue guidance when the Q4 FY2026 call takes place in August; that the 50-day moving average golden cross — which occurred on May 14 — fails to attract the institutional buying that typically follows this technical signal if the fundamental contract outlook remains murky; that the $37.8 million cash balance, while sufficient for several years at the current burn rate, needs to fund increased R&D spending in quantum photonics and scalable compound semiconductor manufacturing scale-up that could accelerate the quarterly cash outflow from the current -$1.8 million quarterly net loss level; and that competition from larger compound semiconductor producers in photonic computing — including companies developing silicon photonics alternatives for AI data center applications — limits ALMU's ability to diversify revenue away from U.S. government contracts into commercial channels before the government procurement environment normalizes.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ALMU

Contributor

Alicia's AvatarAlicia|Beginner

Momentum Indicator for ALMU turns negative, indicating new downward trend

ALMU saw its Momentum Indicator move below the 0 level on August 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 75 similar instances where the indicator turned negative. In of the 75 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ALMU turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALMU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ALMU entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALMU's RSI Indicator exited the oversold zone, of 11 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALMU advanced for three days, in of 125 cases, the price rose further within the following month. The odds of a continued upward trend are .

ALMU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.743) is normal, around the industry mean (7.465). P/E Ratio (0.000) is within average values for comparable stocks, (155.851). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.777). ALMU has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (48.309) is also within normal values, averaging (53.922).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ALMU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALMU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 196.39B. The market cap for tickers in the group ranges from 13.43K to 5.2T. NVDA holds the highest valuation in this group at 5.2T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was -8%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 37%. ICG experienced the highest price growth at 16%, while MXL experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -9%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 55
Price Growth Rating: 52
SMR Rating: 74
Profit Risk Rating: 75
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
ALMU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Profile
Details
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.